Abstract

BackgroundSeveral species of Aspidosperma plants are referred to as remedies for the treatment of malaria, especially Aspidosperma nitidum. Aspidosperma pyrifolium, also a medicinal plant, is used as a natural anti-inflammatory. Its fractionated extracts were assayed in vitro for activity against malaria parasites and for cytotoxicity.MethodsAspidosperma pyrifolium activity was evaluated against Plasmodium falciparum using extracts in vitro. Toxicity towards human hepatoma cells, monkey kidney cells or human monocytes freshly isolated from peripheral blood was also assessed. Anti-malarial activity of selected extracts and fractions that presented in vitro activity were tested in mice with a Plasmodium berghei blood-induced infection.ResultsThe crude stem bark extract and the alkaloid-rich and ethyl acetate fractions from stem extract showed in vitro activity. None of the crude extracts or fractions was cytotoxic to normal monkey kidney and to a human hepatoma cell lines, or human peripheral blood mononuclear cells; the MDL50 values of all the crude bark extracts and fractions were similar or better when tested on normal cells, with the exception of organic and alkaloidic-rich fractions from stem extract. Two extracts and two fractions tested in vivo caused a significant reduction of P. berghei parasitaemia in experimentally infected mice.ConclusionConsidering the high therapeutic index of the alkaloidic-rich fraction from stem extract of A. pyrifolium, it makes the species a candidate for further investigation aiming to produce a new anti-malarial, especially considering that the active extract has no toxicity, i.e., no mutagenic effects in the genototoxicity assays, and that it has an in vivo anti-malarial effect. In its UPLC-HRMS analysis this fraction was shown to have two major components compatible with the bisindole alkaloid Leucoridine B, and a novel compound, which is likely to be responsible for the activity against malaria parasites demonstrated in in vitro tests.

Highlights

  • Several species of Aspidosperma plants are referred to as remedies for the treatment of malaria, especially Aspidosperma nitidum

  • Among 5 crude extracts and 7 different fractions tested against P. falciparum chloroquine-resistant parasites, the best in vitro activity was shown by the crude stem bark extract (AP1) (­IC50 = 3 μg/ ml)

  • The two other species Aspidosperma olivaceum [30] and Aspidosperma ramiflorum [31] showed higher toxicities, resulting in lower selectivity indexes when compared to A. pyrifolium

Read more

Summary

Introduction

Several species of Aspidosperma plants are referred to as remedies for the treatment of malaria, especially Aspidosperma nitidum. Resistance of Plasmodium parasites to classical drugs includes artemisinin derivatives, the latest weapon to fight malaria in areas of drug resistance [1]. First isolated from the Chinese medicinal plant Artemisia annua (sweet wormwood), artemisinin derivatives. New drugs to fight malaria are needed due to the spread of Plasmodium falciparum resistant to available antimalarial drugs [1, 3]. Plasmodium vivax, the species most prevalent in South America, shows resistance to chloroquine, making malaria control more difficult [4,5,6]. Herbal remedies remain important to control malaria in poor, endemic areas [11,12,13,14,15]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call